Stifel Initiates Coverage On Trex Bio with Buy Rating, Announces Price Target of $39
Benzinga Newsdesk 15 hours ago
Analyst RatingsNewsInitiationPrice Target
Stifel analyst Alex Thompson initiates coverage on Trex Bio (NASDAQ:TRXB) with a Buy rating and announces Price Target of $39.
Stifel analyst Alex Thompson initiates coverage on Trex Bio (NASDAQ:TRXB) with a Buy rating and announces Price Target of $39.